Skip to main content
TCI GENE Inc. (TPEX:6879)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
37.00
-0.20 (-0.54%)
Apr 29, 2026, 11:36 AM CST

TCI GENE Revenue

In the year 2025, TCI GENE had annual revenue of 273.61M TWD, down -21.27%. TCI GENE had revenue of 131.90M in the half year ending December 31, 2025, a decrease of -28.31%.

Revenue
273.61M
Revenue Growth
-21.27%
P/S Ratio
3.71
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.02B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025273.61M-73.93M-21.27%
Dec 31, 2024347.54M13.68M4.10%
Dec 31, 2023333.86M-90.17M-21.26%
Dec 31, 2022424.02M-8.20M-1.90%
Dec 31, 2021432.22M239.27M124.01%
Dec 31, 2020 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Taiwan Advance Bio-Pharmaceutical 371.86M
Holy Stone Healthcare 47.51M
Level Biotechnology 736.59M
Lukas Biomedical 180.32M
GeneReach Biotechnology 232.74M
NatureWise Biotech & Medicals 180.29M
Neith 36.15M
Revenue Rankings